Diligence memo · auto-generated · as of July 2, 2026
MOAT BIOTECHNOLOGY Corp
MOAT BIOTECHNOLOGY Corp looks under-valued against its niche peers and is at-risk on financing cadence.
Businessfiled
MOAT BIOTECHNOLOGY Corp operates in Biotechnology, based in OKLAHOMA CITY.
Sub-sector tags: biotech.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
MOAT BIOTECHNOLOGY Corp has raised $1.6M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).
Largest single filing: $1.5M on 2022-06-29.
Most recent recorded round closed around 2023-01-10.
Valuation (modeled)modeled
Provath models MOAT BIOTECHNOLOGY Corp at approximately $1.1M (range $73K–$4.4M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.08× the median modeled value of Seed Biotechnology companies in 2022–2024 (207 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 3 months.
Last raise 3.5 yr ago; this sector typically re-raises about every 14 months.
Past due for a raise versus sector cadence — watch for distress or a bridge.
The last round was 9.8× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 25% of Biotechnology peers (4293 compared).
Modeled value ranks above 3% of those peers.
Closest niche peers: Mesentech Inc., Marlinspike Therapeutics, Inc., Microbial Machines, Inc., Pearl Diagnostics, Inc., Crossfire Medical Inc.
Peoplefiled
16 named people on file across officers, directors and signatories.
Risks & flagsmixed
Overdue for a raise versus sector norm — distress or bridge risk.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.